share_log

Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Moss Dana J

SEC announcement ·  Jul 17, 2023 18:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more